유럽의 농업용 미생물 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the Europe agricultural microbial market size was valued at USD 2.90 billion in 2025 and estimated to grow from USD 3.31 billion in 2026 to reach USD 6.45 billion by 2031, at a CAGR of 14.23% during the forecast period (2026-2031).

This report is Segmented by Type (Bacteria, Fungi, and More), by Application (Grains and Cereals, Pulses and Oilseeds, Commercial Crops, Fruits and Vegetables, and More), by Mode of Application (Soil Treatment, Foliar Spray, and More), and by Geography (Germany, United Kingdom, France, Spain, Italy, Netherlands, Russia, and More). The Market Forecasts are Provided in Terms of Value (USD).

Europe Agricultural Microbial Market Trends and Insights

Increasing Adoption of Organic and Regenerative Farming

Certified organic farmland across the European Union reached 15.9 million hectares in 2024, representing 10.2% of the total utilized agricultural area. France, Spain, and Italy collectively manage over 7 million hectares under organic protocols. Regenerative agriculture, which emphasizes soil health metrics beyond organic certification, is expanding even faster as carbon credit programs and retailer sustainability scorecards reward practices such as cover cropping, reduced tillage, and microbial inoculant use. The trend is most pronounced in Germany and France, where large-scale arable farms possess the agronomic expertise and equipment to integrate microbials into precision-seeding workflows, yet smaller Mediterranean holdings in Spain and Italy are catching up as cooperative extension services disseminate application protocols tailored to high-value horticultural crops.

European Union Farm-to-Fork Pesticide-Reduction Mandates

The European Commission's Farm-to-Fork strategy, adopted in 2020 and reinforced through 2024 legislative updates, mandates a 50% reduction in chemical pesticide use and risk by 2030, creating a regulatory void that biological alternatives must fill . Member states are translating this target into national action plans. For instance, France has committed to phasing out glyphosate and neonicotinoids ahead of the Europe Union-wide deadline, while Germany has introduced stricter buffer zones around water bodies that effectively ban many conventional sprays. These restrictions are accelerating the adoption of microbes in two ways. First, they remove chemical competitors from the market, forcing growers to trial bacterial and fungal biocontrols for diseases such as botrytis and powdery mildew. The regulatory influence of the European Union's Sustainable Use of Pesticides Directive further reinforces this shift by requiring integrated pest management plans that prioritize non-chemical methods, embedding microbials into the compliance framework rather than treating them as optional add-ons.

High Upfront Product and Distribution Costs

Microbial products typically cost 20 to 40% more per hectare than chemical equivalents, a price gap driven by fermentation, cold-storage, and shorter shelf-life economics that inflate production and distribution expenses. For smallholder farms in Southern and Eastern Europe, where average holdings range from 3 to 8 hectares, and cash-flow constraints limit input budgets, this premium represents a meaningful barrier to trial adoption. Growers operating on thin margins prioritize inputs with proven, immediate returns, whereas microbials often require multi-season observation to demonstrate cumulative soil-health benefits that justify higher costs. Distribution infrastructure compounds the challenge, as microbial products demand refrigerated transport and storage to maintain viable cell counts, adding logistics expenses that chemical distributors avoid. In Poland and Romania, where rural cold-chain networks remain underdeveloped, distributors pass these costs to end users, further widening the price gap. Some manufacturers are responding by offering pay-for-performance contracts that tie payment to yield outcomes, yet these arrangements require third-party verification and remain rare outside Western European markets, where agronomic advisory services can monitor trial plots and document results.

Other drivers and restraints analyzed in the detailed report include:

1. Consumer Demand for Residue-Free Produce
2. Expansion of European Union Carbon-Credit Schemes Rewarding Bio-Fertilizer Use
3. Limited Farmer Awareness and Training Gaps

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Bacteria-based microbials captured 64.70% of the Europe agricultural microbial market size in 2025, anchored by established genera such as Bacillus, Pseudomonas, and Rhizobium that deliver proven efficacy in nitrogen fixation, phosphate solubilization, and biocontrol of fungal pathogens. The bacterial segment's maturity is attracting consolidation, with BASF SE and Bayer AG acquiring smaller inoculant firms to secure proprietary strains and fermentation capacity. Fungal products are benefiting from recent innovations in liquid formulations, which improve shelf stability and field application uniformity compared to traditional wettable powders. Regulatory frameworks under the Europe Biocidal Products Regulation and Plant Protection Products Regulation influence approval timelines, with bacterial and fungal strains often qualifying for expedited review when they exhibit low mammalian toxicity and environmental persistence.

Fungi microbials are expanding at a 15.12% CAGR through 2031, driven by grower demand for dual-function products that suppress soil-borne diseases while improving soil structure and organic matter content. Viral microbials, dominated by baculoviruses targeting lepidopteran pests, serve niche applications in high-value crops where highly specific pest control justifies premium pricing and minimizes non-target impacts on beneficial insects. Protozoa remain an emerging segment, primarily applied in controlled-environment agriculture to suppress soil-borne nematodes and root pathogens. However, research into field-scale formulations is accelerating as production costs decline.

Complete Report Scope:

• By Type
  • Bacteria
  • Fungi
  • Others
• By Application
  • Fruits and Vegetables
  • Grains and Cereals
  • Pulses and Oilseeds
  • Commercial Crops
  • Other Crop Types
• By Mode of Application
  • Soil Treatment
  • Foliar Spray
  • Seed Treatment
• By Geography
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Turkey
  • Russia
  • Rest of Europe

List of Companies Covered in this Report:

1. BASF SE
2. Bayer AG
3. Syngenta Group Co. Ltd.
4. Corteva Inc.
5. Koppert Group B.V.
6. Novonesis A/S
7. UPL Limited
8. Bioceres Crop Solutions Corp.
9. Lallemand Inc.
10. FMC Corporation
11. Mitsui & Co., Ltd.
12. Andermatt Group AG
13. Biobest Group NV
14. Sumitomo Chemical Co., Ltd.
15. AEA Investors LP

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing adoption of organic and regenerative farming
  • 4.2.2 European Union Farm-to-Fork pesticide-reduction mandates
  • 4.2.3 Consumer demand for residue-free produce
  • 4.2.4 Expansion of European Union carbon-credit schemes rewarding bio-fertilizer use
  • 4.2.5 AI-guided microbiome formulations boosting field efficacy
  • 4.2.6 Post-Brexit United Kingdom fast-track pathway for biological registrations
• 4.3 Market Restraints
  • 4.3.1 High upfront product and distribution costs
  • 4.3.2 Limited farmer awareness and training gaps
  • 4.3.3 Lengthy two-step European Union microbial registration process
  • 4.3.4 Cold-chain and logistics gaps in Central and Eastern Europe
• 4.4 Regulatory Landscape
• 4.5 Porter's Five Forces Analysis
  • 4.5.1 Bargaining Power of Suppliers
  • 4.5.2 Bargaining Power of Buyers
  • 4.5.3 Threat of New Entrants
  • 4.5.4 Threat of Substitutes
  • 4.5.5 Intensity of Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

• 5.1 By Type
  • 5.1.1 Bacteria
  • 5.1.2 Fungi
  • 5.1.3 Others
• 5.2 By Application
  • 5.2.1 Fruits and Vegetables
  • 5.2.2 Grains and Cereals
  • 5.2.3 Pulses and Oilseeds
  • 5.2.4 Commercial Crops
  • 5.2.5 Other Crop Types
• 5.3 By Mode of Application
  • 5.3.1 Soil Treatment
  • 5.3.2 Foliar Spray
  • 5.3.3 Seed Treatment
• 5.4 By Geography
  • 5.4.1 Germany
  • 5.4.2 France
  • 5.4.3 United Kingdom
  • 5.4.4 Italy
  • 5.4.5 Spain
  • 5.4.6 Turkey
  • 5.4.7 Russia
  • 5.4.8 Rest of Europe

6 COMPETITIVE LANDSCAPE

• 6.1 Strategic Moves
• 6.2 Market Share Analysis
• 6.3 Company Profiles (Includes Global Level Overview, Market Level Overview, Core Segments, Financials as Available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 BASF SE
  • 6.3.2 Bayer AG
  • 6.3.3 Syngenta Group Co. Ltd.
  • 6.3.4 Corteva Inc.
  • 6.3.5 Koppert Group B.V.
  • 6.3.6 Novonesis A/S
  • 6.3.7 UPL Limited
  • 6.3.8 Bioceres Crop Solutions Corp.
  • 6.3.9 Lallemand Inc.
  • 6.3.10 FMC Corporation
  • 6.3.11 Mitsui & Co., Ltd.
  • 6.3.12 Andermatt Group AG
  • 6.3.13 Biobest Group NV
  • 6.3.14 Sumitomo Chemical Co., Ltd.
  • 6.3.15 AEA Investors LP

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK